Average Co-Inventor Count = 5.40
ph-index = 11
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. The United States of America, As Represented by the Secretary, Department of Health and Human Services (18 from 3,539 patents)
2. The United States of America As Represented by the Secretary of (3 from 2,202 patents)
3. The University Court of the University of Aberdeen (3 from 49 patents)
4. P2d, Inc. (3 from 4 patents)
5. The United States of America As Represented by the Department of Health (2 from 1,217 patents)
6. Peptron, Inc. (2 from 10 patents)
7. Raptor Pharmaceutical Corp (2 from 6 patents)
8. Other (1 from 832,843 patents)
9. Axonyx, Inc. (1 from 5 patents)
10. The National Institutes of Health and Axonyx, Inc. (1 from 1 patent)
11. Torreypines Therapeutics, Inc. (1 patent)
12. Giordano, Tony (0 patent)
13. Brossi, Arnold (0 patent)
14. Soncrant, Timothy T. (0 patent)
27 patents:
1. 11771657 - Methods of delivering a neuroprotective polypeptide to the central nervous system
2. 11440880 - Thalidomide analogs and methods of use
3. 11273130 - Methods of delivering a neuroprotective polypeptide to the central nervous system
4. 10941187 - GLP-1, exendin-4, peptide analogs and uses thereof
5. 10836721 - Thalidomide analogs and methods of use
6. 10730835 - Thalidomide analogs and methods of use
7. 10220028 - Thio compounds
8. 9623020 - Thio compounds
9. 8927725 - Thio compounds
10. 8853160 - GLP-1, exendin-4, peptide analogs and uses thereof
11. 8853253 - Thalidomide analogs
12. 8691864 - Agents useful for reducing amyloid precursor protein and treating dementia and methods of use thereof
13. 8546430 - Thalidomide analogs
14. 8278272 - GLP-1, exendin-4, peptide analogs and uses thereof
15. 8258172 - Agents useful for reducing amyloid precursor protein and treating dementia and methods of use thereof